Log in

Relevant bibliographies by topics / Phosphoribosyltransferase / Journal articles

Journal articles on the topic 'Phosphoribosyltransferase'

To see the other types of publications on this topic, follow the link: Phosphoribosyltransferase.

Author: Grafiati

Published: 4 June 2021

Last updated: 4 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Phosphoribosyltransferase.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Fateev, Ilja V., Ekaterina V. Sinitsina, Aiguzel U. Bikanasova, Maria A. Kostromina, Elena S. Tuzova, Larisa V. Esipova, Tatiana I. Muravyova, Alexei L. Kayushin, Irina D. Konstantinova, and Roman S. Esipov. "Thermophilic phosphoribosyltransferases Thermus thermophilus HB27 in nucleotide synthesis." Beilstein Journal of Organic Chemistry 14 (December 21, 2018): 3098–105. http://dx.doi.org/10.3762/bjoc.14.289.

Full text

Abstract:

Phosphoribosyltransferases are the tools that allow the synthesis of nucleotide analogues using multi-enzymatic cascades. The recombinant adenine phosphoribosyltransferase (TthAPRT) and hypoxanthine phosphoribosyltransferase (TthHPRT) from Thermus thermophilus HB27 were expressed in E.coli strains and purified by chromatographic methods with yields of 10–13 mg per liter of culture. The activity dependence of TthAPRT and TthHPRT on different factors was investigated along with the substrate specificity towards different heterocyclic bases. The kinetic parameters for TthHPRT with natural substrates were determined. Two nucleotides were synthesized: 9-(β-D-ribofuranosyl)-2-chloroadenine 5'-monophosphate (2-Сl-AMP) using TthAPRT and 1-(β-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine-4-one 5'-monophosphate (Allop-MP) using TthНPRT.

APA, Harvard, Vancouver, ISO, and other styles

2

Aklujkar, Muktak. "Two ATP phosphoribosyltransferase isozymes of Geobacter sulfurreducens contribute to growth in the presence or absence of histidine and under nitrogen fixation conditions." Canadian Journal of Microbiology 57, no. 7 (July 2011): 547–58. http://dx.doi.org/10.1139/w11-047.

Full text

Abstract:

Bacteria of the Geobacter clade possess two distinct ATP phosphoribosyltransferases encoded by hisGL and hisGS+hisZ to catalyze the first reaction of histidine biosynthesis. This very unusual redundancy was investigated by mutational analysis. The hisGL, hisGS, and hisZ genes of Geobacter sulfurreducens were deleted, effects on growth and histidine biosynthesis gene expression were evaluated, and deficiencies were complemented with plasmid-borne genes. Both hisGL and hisGS+hisZ encode functional ATP phosphoribosyltransferases. However, deletion of hisGL resulted in no growth defect, whereas deletion of hisGS delayed growth when histidine was not provided. Both deletions increased hisZ transcript abundance, and both ΔhisGS and ΔhisZ mutations increased hisGL transcript abundance. Growth with HisGL alone (due to deletion of either hisGS or hisZ) was better under nitrogen fixation conditions than when ammonium was provided. Deletion of hisZ caused growth defects under all conditions tested, with or without exogenous sources of histidine, with different patterns of histidine biosynthesis gene expression under each condition. Taken together, the data indicate that G. sulfurreducens depends primarily on the HisGSZ isozyme as an ATP phosphoribosyltransferase in histidine biosynthesis, and for other functions when histidine is available; however, HisGL also functions as ATP phosphoribosyltransferase, particularly during nitrogen fixation.

APA, Harvard, Vancouver, ISO, and other styles

3

Sauer, Jørgen, and Per Nygaard. "Expression of the Methanobacterium thermoautotrophicum hpt Gene, Encoding Hypoxanthine (Guanine) Phosphoribosyltransferase, in Escherichia coli." Journal of Bacteriology 181, no. 6 (March 15, 1999): 1958–62. http://dx.doi.org/10.1128/jb.181.6.1958-1962.1999.

Full text

Abstract:

ABSTRACT The hpt gene from the archaeon Methanobacterium thermoautotrophicum, encoding hypoxanthine (guanine) phosphoribosyltransferase, was cloned by functional complementation into Escherichia coli. The hpt-encoded amino acid sequence is most similar to adenine phosphoribosyltransferases, but the encoded enzyme has activity only with hypoxanthine and guanine. The synthesis of the recombinant enzyme is apparently limited by the presence of the rare arginine codons AGA and AGG and the rare isoleucine AUA codon on the hpt gene. The recombinant enzyme was purified to apparent homogeneity.

APA, Harvard, Vancouver, ISO, and other styles

4

Bollée, Guillaume, Jérôme Harambat, Albert Bensman, Bertrand Knebelmann, Michel Daudon, and Irène Ceballos-Picot. "Adenine Phosphoribosyltransferase Deficiency." Clinical Journal of the American Society of Nephrology 7, no. 9 (June 14, 2012): 1521–27. http://dx.doi.org/10.2215/cjn.02320312.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Kadziola, A., K. S. Jensen, A. Mølgaard, J. C. N. Poulsen, and K. F. Jensen. "Sulfolobus solfataricusadenine phosphoribosyltransferase." Acta Crystallographica Section A Foundations of Crystallography 67, a1 (August 22, 2011): C786—C787. http://dx.doi.org/10.1107/s0108767311080093.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Munagala, Narsimha, Anne E. Sarver, and Ching C. Wang. "Converting the Guanine Phosphoribosyltransferase fromGiardia lambliato a Hypoxanthine-guanine Phosphoribosyltransferase." Journal of Biological Chemistry 275, no. 47 (September 6, 2000): 37072–77. http://dx.doi.org/10.1074/jbc.m007239200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

OLIVEIRA, DENILSON F., HELVÉCIO M. DOS SANTOS JÚNIOR, ALEXANDRO S. NUNES, VICENTE P. CAMPOS, RENATA S. C. DE PINHO, and GIOVANNA C. GAJO. "Purification and identification of metabolites produced by Bacillus cereus and B. subtilis active against Meloidogyne exigua, and their in silico interaction with a putative phosphoribosyltransferase fromM. incognita." Anais da Academia Brasileira de Ciências 86, no. 2 (June 2014): 525–38. http://dx.doi.org/10.1590/0001-3765201402412.

Full text

Abstract:

To contribute to the development of products to controlMeloidogyne exigua, the bacteria Bacillus cereus and B. subtilis were cultivated in liquid medium to produce metabolites active against this plant-parasitic nematode. Fractionation of the crude dichloromethane extracts obtained from the cultures afforded uracil, 9H-purine and dihydrouracil. All compounds were active against M. exigua, the latter being the most efficient. This substance presented a LC50 of 204 µg/mL against the nematode, while a LC50 of 260 µg/mL was observed for the commercial nematicide carbofuran. A search for protein-ligand complexes in which the ligands were structurally similar to dihydrouracil resulted in the selection of phosphoribosyltransferases, the sequences of which were used in an in silico search in the genome of M. incognita for a similar sequence of amino acids. The resulting sequence was modelled and dihydrouracil and 9H-purine were inserted in the active site of this putative phosphoribosyltransferase resulting in protein-ligand complexes that underwent molecular dynamics simulations. Calculation of the binding free-energies of these complexes revealed that the dissociation constant of dihydrouracil and 9H-purine to this protein is around 8.3 x 10-7 and 1.6 x 10-6 M, respectively. Consequently, these substances and the putative phosphoribosyltransferase are promising for the development of new products to control M. exigua.

APA, Harvard, Vancouver, ISO, and other styles

8

Jardim, Armando, Susan E. Bergeson, Sarah Shih, Nicola Carter, Randall W. Lucas, Gilles Merlin, Peter J. Myler, Kenneth Stuart, and Buddy Ullman. "Xanthine Phosphoribosyltransferase fromLeishmania donovani." Journal of Biological Chemistry 274, no. 48 (November 26, 1999): 34403–10. http://dx.doi.org/10.1074/jbc.274.48.34403.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Pittelli, Maria, Laura Formentini, Giuseppe Faraco, Andrea Lapucci, Elena Rapizzi, Francesca Cialdai, Giovanni Romano, Gloriano Moneti, Flavio Moroni, and Alberto Chiarugi. "Inhibition of Nicotinamide Phosphoribosyltransferase." Journal of Biological Chemistry 285, no. 44 (August 19, 2010): 34106–14. http://dx.doi.org/10.1074/jbc.m110.136739.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

OLESEN, UFFE HØGH, NINA HASTRUP, and MAXWELL SEHESTED. "Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas." APMIS 119, no. 4-5 (March 25, 2011): 296–303. http://dx.doi.org/10.1111/j.1600-0463.2011.02733.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Nishida, Y., and T. Miyamoto. "Simple Screening Methods for Hypoxanthine-Guanine Phosphoribosyltransferase and Adenine Phosphoribosyltransferase Deficiencies Using Dried Blood Spots on Filter Paper." Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 23, no. 5 (September 1986): 529–32. http://dx.doi.org/10.1177/000456328602300507.

Full text

Abstract:

Simple methods for the detection of hypoxanthine-guanine phosphoribosyltransferase and/or adenine phosphoribosyltransferase deficiencies using dried filter paper blood spots were studied. Enzyme activities in the eluate from dried filter paper blood spots stored for 4 weeks at room conditions were shown to be quite stable. Autoradiographs prepared from dried filter paper blood spots and DE-81 papers soaked with enzyme reaction mixtures containing 14C-hypoxanthine and/or 14C-adenine showed sharp radioactive spots in normal subjects. No activity was evident in the cases of the Lesch-Nyhan syndrome and/or adenine phosphoribosyltransferase deficiency. The methods seem to be suitable for screening.

APA, Harvard, Vancouver, ISO, and other styles

12

CURTO, Raul, O. Eberhard VOIT, and Marta CASCANTE. "Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man." Biochemical Journal 329, no. 3 (February 1, 1998): 477–87. http://dx.doi.org/10.1042/bj3290477.

Full text

Abstract:

A modelling approach is used to analyse diseases associated with purine metabolism in man. The specific focus is on deficiencies in two enzymes, hypoxanthine:guanine phosphoribosyltransferase and adenylosuccinate lyase. These deficiencies can lead to a number of symptoms, including neurological dysfunctions and mental retardation. Although the biochemical mechanisms of dysfunctions associated with adenylosuccinate lyase deficiency are not completely understood, there is at least general agreement in the literature about possible causes. Simulations with our model confirm that accumulation of the two substrates of the enzyme can lead to significant biochemical imbalance. In hypoxanthine:guanine phosphoribosyltransferase deficiency the biochemical mechanisms associated with neurological dysfunctions are less clear. Model analyses support some old hypotheses but also suggest new indicators for possible causes of neurological dysfunctions associated with this deficiency. Hypoxanthine:guanine phosphoribosyltransferase deficiency is known to cause hyperuricaemia and gout. We compare the relative importance of this deficiency with other known causes of gout in humans. The analysis suggests that defects in the excretion of uric acid are more consequential than defects in uric acid synthesis such as hypoxanthine:guanine phosphoribosyltransferase deficiency.

APA, Harvard, Vancouver, ISO, and other styles

13

Vos, Siska, John de Jersey, and Jennifer L. Martin. "Crystal Structure ofEscherichia coliXanthine Phosphoribosyltransferase†." Biochemistry 36, no. 14 (April 1997): 4125–34. http://dx.doi.org/10.1021/bi962640d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Takahashi, Ryo, Shota Nakamura, Takuya Yoshida, Yuji Kobayashi, and Tadayasu Ohkubo. "Crystallization of human nicotinamide phosphoribosyltransferase." Acta Crystallographica Section F Structural Biology and Crystallization Communications 63, no. 5 (April 6, 2007): 375–77. http://dx.doi.org/10.1107/s1744309107006069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Scapin, Giovanna, Charles Grubmeyer, and James C. Sacchettini. "Crystal Structure of Orotate Phosphoribosyltransferase." Biochemistry 33, no. 6 (February 15, 1994): 1287–94. http://dx.doi.org/10.1021/bi00172a001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Raman, Jayalakshmi, Chethan S. Ashok, Sujay I.N. Subbayya, Ranjith P. Anand, Senthamizh T. Selvi, and Hemalatha Balaram. "Plasmodium falciparum hypoxanthine guanine phosphoribosyltransferase." FEBS Journal 272, no. 8 (March 29, 2005): 1900–1911. http://dx.doi.org/10.1111/j.1742-4658.2005.04620.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

LAXDAL, THRÖSTUR, and TÓMAS Á. JÓNASSON. "Adenine Phosphoribosyltransferase Deficiency in Iceland." Acta Medica Scandinavica 224, no. 6 (April 24, 2009): 621–26. http://dx.doi.org/10.1111/j.0954-6820.1988.tb19635.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Árnadóttir, Margrét. "Febuxostat in Adenosine Phosphoribosyltransferase Deficiency." American Journal of Kidney Diseases 64, no. 2 (August 2014): 316. http://dx.doi.org/10.1053/j.ajkd.2014.04.026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Torres, R. J., S. Puente, A. Menendez, and N. Fernandez-Garcia. "Unapparent hypoxanthine-guanine phosphoribosyltransferase deficiency." Clinica Chimica Acta 472 (September 2017): 136–38. http://dx.doi.org/10.1016/j.cca.2017.08.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Harambat, Jérôme, Guillaume Bollée, Michel Daudon, Irène Ceballos-Picot, and Albert Bensman. "Adenine phosphoribosyltransferase deficiency in children." Pediatric Nephrology 27, no. 4 (January 3, 2012): 571–79. http://dx.doi.org/10.1007/s00467-011-2037-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Davidson, B. L., M. Pashmforoush, W. N. Kelley, and T. D. Palella. "Human Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency." Journal of Biological Chemistry 264, no. 1 (January 1989): 520–25. http://dx.doi.org/10.1016/s0021-9258(17)31289-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Syed, Danyal B., and Donald L. Sloan. "Orotate phosphoribosyltransferase and hypoxanthine/guanine phosphoribosyltransferase from yeast: Kinetic analysis with chromium(III) pyrophosphate." Journal of Inorganic Biochemistry 38, no. 2 (February 1990): 127–38. http://dx.doi.org/10.1016/0162-0134(90)84021-g.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Ikeda, Kazumasa, Harudo Suzuki, and Shigeki Nakagawa. "Human brain hypoxanthine guanine phosphoribosyltransferase: Structural and functional comparison with erythrocyte hypoxanthine guanine phosphoribosyltransferase." International Journal of Biochemistry 18, no. 7 (January 1986): 575–81. http://dx.doi.org/10.1016/0020-711x(86)90236-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Allen, Thomas, Eugene V. Henschel, Terry Coons, Laura Cross, Joseph Conley, and Buddy Ullman. "Purification and characterization of the adenine phosphoribosyltransferase and hypoxanthine-guanine phosphoribosyltransferase activities from Leishmania donovani." Molecular and Biochemical Parasitology 33, no. 3 (March 1989): 273–81. http://dx.doi.org/10.1016/0166-6851(89)90089-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Grubmeyer, C., E. Segura, and R. Dorfman. "Active site lysines in orotate phosphoribosyltransferase." Journal of Biological Chemistry 268, no. 27 (September 1993): 20299–304. http://dx.doi.org/10.1016/s0021-9258(20)80728-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Tao, Wen, Charles Grubmeyer, and John S. Blanchard. "Transition State Structure ofSalmonella typhimuriumOrotate Phosphoribosyltransferase†." Biochemistry 35, no. 1 (January 1996): 14–21. http://dx.doi.org/10.1021/bi951898l.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Shackelford, R. E., K. Mayhall, N. M. Maxwell, E. Kandil, and D. Coppola. "Nicotinamide Phosphoribosyltransferase in Malignancy: A Review." Genes & Cancer 4, no. 11-12 (October 30, 2013): 447–56. http://dx.doi.org/10.1177/1947601913507576.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Foster, Alan C., William C. Zinkand, and Robert Schwarcz. "Quinolinic Acid Phosphoribosyltransferase in Rat Brain." Journal of Neurochemistry 44, no. 2 (February 1985): 446–54. http://dx.doi.org/10.1111/j.1471-4159.1985.tb05435.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Wang, Pei, Yun-Feng Guan, Wen-Lin Li, Guo-Cai Lu, Jian-Min Liu, and Chao-Yu Miao. "Nicotinamide Phosphoribosyltransferase Facilitates Post-Stroke Angiogenesis." CNS Neuroscience & Therapeutics 21, no. 5 (March 9, 2015): 475–77. http://dx.doi.org/10.1111/cns.12388.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Runolfsdottir, Hrafnhildur Linnet, Runolfur Palsson, Inger M. Agustsdottir, Olafur S. Indridason, and Vidar O. Edvardsson. "Kidney Disease in Adenine Phosphoribosyltransferase Deficiency." American Journal of Kidney Diseases 67, no. 3 (March 2016): 431–38. http://dx.doi.org/10.1053/j.ajkd.2015.10.023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Williamson, D. J., M. L. Hooper, and D. W. Melton. "Mouse models of hypoxanthine phosphoribosyltransferase deficiency." Journal of Inherited Metabolic Disease 15, no. 4 (July 1992): 665–73. http://dx.doi.org/10.1007/bf01799622.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Chiba, P., K. Zwiauer, and M. M. Müller. "Characterization of an adenine phosphoribosyltransferase deficiency." Clinica Chimica Acta 172, no. 2-3 (March 1988): 141–47. http://dx.doi.org/10.1016/0009-8981(88)90318-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Campillo, Nuria, Hampapathalu A. Nagarajaram, and Indira Ghosh. "Phosphoribosyltransferase superfamily: A comparative structural analysis." Journal of Molecular Modeling 7, no. 4 (May 2001): 80–89. http://dx.doi.org/10.1007/s008940000001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Colombo, G., D. G. Ribaldone, G. P. Caviglia, A. Genazzani, and C. Travelli. "P072 The involvement of extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) and Nicotinate Phosphoribosyltransferase (eNAPRT) in inflammatory bowel disease." Journal of Crohn's and Colitis 15, Supplement_1 (May 1, 2021): S175—S176. http://dx.doi.org/10.1093/ecco-jcc/jjab076.201.

Full text

Abstract:

Abstract Background Nicotinamide phosphoribosyltrasferase (NAMPT) is a pleiotropic enzyme which catalyses the first and rate-limiting step in the biosynthesis of NAD. It is present in two different forms: an intracellular form, called iNAMPT, (Chiarugi et al., 2012), and an extracellular form, eNAMPT. eNAMPT is considered an important factor for granulocyte-colony stimulating factor-(G-CSF)-induced myeloid differentiation, with paracrine and autocrine effects on different cell types (i.e. immune and cancer cells), binding TLR4. NAMPT is structurally and functionally related to the enzyme nicotinate phosphoribosyltransferase (iNAPRT), which is rate-limiting in the NAD salvage pathway that starts from nicotinic acid. The NAD biosynthetic pathways controlled by NAMPT and NAPRT are closely interconnected and can compensate for each other. Also, NAPRT is identified as an extracellular ligand (eNAMPRT) for TLR4 and a mediator of inflammation (Managò et al., 2020). Importantly, iNAMPT and eNAMPT levels are increased in several pathologies, included inflammatory bowel disease (IBD). It has been reported that serum eNAMPT levels correlate with the stage of the pathology: in an active state of the disease the levels of NAMPT are very high, however its levels are partially reduced in a remission stage (Moschen et al., 2007). Methods First, we investigated the role of eNAMPT and eNAPRT in murine IBD models (especially in DNBS and DSS model). We took into account phenotypic effect as weight loss and colon shortening, but also the reduction of mRNA of inflammatory genes with RT-PCR, tissue damage with H&E and IHC analysis and systemic and local production through colon explant. Secondly, we determined serum eNAMPT and eNAPRT levels in a cohort of adult IBD patients. Results Both eNAMPT and eNAPRT have been found elevated in 180 IBD patients, as proinflammatory marker of the pathologies. These levels are also elevated in serum and colonic explant of DSS and DNBS preclinical models, associated to an active state of the disease, as a pro-inflammatory response developed locally and systemically. Moreover, we performed ELISA analysis on sera of 100 IBD patients, eligible for anti-TNF treatment, both pediatric and adults. Serum eNAMPT levels are increased before the treatment, responsive patients verified a reduction of these levels, while no-responsive ones verified higher levels. Conclusion eNAMPT and eNAPRT could be considered pro-inflammatory markers of IBD and possible druggable targets.

APA, Harvard, Vancouver, ISO, and other styles

35

Santiago, Manuel F., and Thomas P. West. "Control of pyrimidine formation in Pseudomonas putida ATCC 17536." Canadian Journal of Microbiology 48, no. 12 (December 1, 2002): 1076–81. http://dx.doi.org/10.1139/w02-110.

Full text

Abstract:

The regulation of de novo pyrimidine biosynthesis in Pseudomonas putida ATCC 17536 by pyrimidines was explored. The pathway enzyme activities were higher in glucose-grown cells than in succinate-grown cells, indicating catabolite repression by succinate. In P. putida cells grown on succinate as a carbon source, only aspartate transcarbamoylase activity was greatly diminished by uracil supplementation. When glucose was the carbon source, orotic acid supplementation significantly decreased orotate phosphoribosyltransferase and orotidine 5'-monophosphate (OMP) decarboxylase activities. Uracil auxotrophs, deficient for dihydroorotase activity or with reduced phosphoribosyltransferase activity, were isolated. After pyrimidine limitation of both auxotrophs, the greatest derepression of enzyme activity was observed for OMP decarboxylase independent of carbon source. Orotic acid induced both phosphoribosyltransferase and decarboxylase activities in glucose-grown cells of the dihydroorotase-deficient strain. Regulation at the transcriptional level of de novo pyrimidine biosynthetic enzyme synthesis in P. putida ATCC 17536 was observed, which contrasts with previous observations.Key words: pyrimidine biosynthesis, regulation, auxotrophs, induction, Pseudomonas.

APA, Harvard, Vancouver, ISO, and other styles

36

INAGAKI, Kenjiroh, Akihiro MURAOKA, Itsuo SUEHIRO, Masatoshi FUJII, Hirohisa UENO, Tetsuya HOSOOKA, Kazuhisa KIDA, and Keiji MURAKAMI. "Partial Adenine Phosphoribosyltransferase Deficiency Detected by Ureterolithiasis." Internal Medicine 37, no. 1 (1998): 69–72. http://dx.doi.org/10.2169/internalmedicine.37.69.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Bollée, Guillaume. "Adenine phosphoribosyltransferase deficiency: Leave no stone unturned." World Journal of Clinical Urology 3, no. 3 (2014): 218. http://dx.doi.org/10.5410/wjcu.v3.i3.218.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Benedetto, Bernard, Robert Madden, Alexander Kurbanov, Gregory Braden, Jonathan Freeman, and George S. Lipkowitz. "Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction." American Journal of Kidney Diseases 37, no. 5 (May 2001): e37.1-e37.4. http://dx.doi.org/10.1016/s0272-6386(05)90001-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Moggré, Gert-Jan, Myles B. Poulin, Peter C. Tyler, Vern L. Schramm, and Emily J. Parker. "Transition State Analysis of Adenosine Triphosphate Phosphoribosyltransferase." ACS Chemical Biology 12, no. 10 (September 19, 2017): 2662–70. http://dx.doi.org/10.1021/acschembio.7b00484.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Shi, Wuxian, Kelly S. E. Tanaka, Timothy R. Crother, Milton W. Taylor, Steven C. Almo, and Vern L. Schramm. "Structural Analysis of Adenine Phosphoribosyltransferase fromSaccharomyces cerevisiae†,‡." Biochemistry 40, no. 36 (September 2001): 10800–10809. http://dx.doi.org/10.1021/bi010465h.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Bashor, Caleb, John M. Denu, Richard G. Brennan, and Buddy Ullman. "Kinetic Mechanism of Adenine Phosphoribosyltransferase fromLeishmania donovani†." Biochemistry 41, no. 12 (March 2002): 4020–31. http://dx.doi.org/10.1021/bi0158730.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Sumi, Satoshi, Mitsuhiro Andou, Naoki Hamajima, Kiyoshi Kidouchi, Hajime Togari, and Yoshiro Wada. "Uracil phosphoribosyltransferase activity in hereditary orotic aciduria." Clinica Chimica Acta 283, no. 1-2 (May 1999): 201–3. http://dx.doi.org/10.1016/s0009-8981(99)00003-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Cho, Yoonsang, Vivek Sharma, and James C. Sacchettini. "Crystal Structure of ATP Phosphoribosyltransferase fromMycobacterium tuberculosis." Journal of Biological Chemistry 278, no. 10 (January 2, 2003): 8333–39. http://dx.doi.org/10.1074/jbc.m212124200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

HOMMEL, Ulrich, Ariel LUSTIG, and Kasper KIRSCHNER. "Purification and characterization of yeast anthranilate phosphoribosyltransferase." European Journal of Biochemistry 180, no. 1 (March 1989): 33–40. http://dx.doi.org/10.1111/j.1432-1033.1989.tb14611.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Galli, Ubaldina, Cristina Travelli, Alberto Massarotti, Gohar Fakhfouri, Reza Rahimian, Gian Cesare Tron, and Armando A. Genazzani. "Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors." Journal of Medicinal Chemistry 56, no. 16 (May 31, 2013): 6279–96. http://dx.doi.org/10.1021/jm4001049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hirsh, Sharon M., and Rodney E. Shackelford. "Nicotinamide Phosphoribosyltransferase Overexpression in Renal Cell Carcinomas." American Journal of Clinical Pathology 138, suppl 1 (July 1, 2012): A107. http://dx.doi.org/10.1093/ajcp/138.suppl1.102.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Doyle, Patricia S., Jamil Kanaani, and Ching C. Wang. "Hypoxanthine, Guanine, Xanthine Phosphoribosyltransferase Activity inCryptosporidium parvum." Experimental Parasitology 89, no. 1 (May 1998): 9–15. http://dx.doi.org/10.1006/expr.1998.4263.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Ceballos-Picot, Irène, Abhijeet Saha, Nimisha Arora, Kanika Kapoor, Manpreet Kaur, Rachita Singh Dhull, and Samridhi Goyal. "Adenine Phosphoribosyltransferase Deficiency Due to Novel Mutation." Kidney International Reports 4, no. 4 (April 2019): 624–28. http://dx.doi.org/10.1016/j.ekir.2018.12.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Dahl, Tuva, Trine Ranheim, Sverre Holm, Rolf Berge, Pål Aukrust, and Bente Halvorsen. "Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages." European Journal of Clinical Investigation 41, no. 10 (March 22, 2011): 1098–104. http://dx.doi.org/10.1111/j.1365-2362.2011.02515.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Grolla, Ambra A., Cristina Travelli, Armando A. Genazzani, and Jaswinder K. Sethi. "Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine." British Journal of Pharmacology 173, no. 14 (June 2, 2016): 2182–94. http://dx.doi.org/10.1111/bph.13505.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!